| [1] | Bakkers M. J. G., Ritschel T., Tiemessen M, et al. (2024). Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer. Nat. Commun. 15:6270. DOI:10.1038/s41467-024-50659-5 |
| [2] | Lee Y. Z., Han J., Zhang Y. N., et al. (2024). Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat. Commun. 15:9939. DOI:10.1038/s41467-024-54287-x |
| [3] | Cao W., Xu J., Liu Z., et al. (2024). Poor clinical outcomes in respiratory viral sepsis: A retrospective observational study. ERJ Open Res. in press. DOI: 10.1183/23120541.00836-2024. |
| [4] | Kapandji N., Darmon M., Valade S., et al. (2023). Clinical significance of human metapneumovirus detection in critically ill adults with lower respiratory tract infections. Ann. Intensive Care 13:21. DOI:10.1186/s13613-023-01117-w |
| [5] | Perez A., Gomez D., Montoro J., et al. (2024). Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease. Bone Marrow Transplant. 59:1118−26. DOI:10.1038/s41409-024-02304-4 |
| Cao W., Xu J., Zhu F., et al. (2025). Addressing the unmet needs: Optimized vaccine design for human metapneumovirus. The Innovation Medicine 3:100112. https://doi.org/10.59717/j.xinn-med.2025.100112 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Comparisons of clinical diagnosis, treatment, and prevention of several respiratory viruses